ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CYAD Celyad Oncology SA

0.35
0.00 (0.00%)
05 Nov 2024 - Closed
Delayed by 15 minutes

Celyad Oncology Financial Summary

The current CYAD market cap is 14.5M. The company's latest EPS is EUR -0.2039 and P/E is -1.72.

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 6k5k00102k
Operating Income -28.88M-16.99M-26.39M-40.86M-9.54M
Net Income -28.63M-17.2M-26.51M-40.94M-8.45M
Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 89.84M66.08M79.94M19.72M16.28M
Total Liabilities 44.22M35.09M36.3M15.4M9.98M
Total Equity 45.62M30.99M43.64M4.32M6.3M

Cash Flow

Year End 31 December 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating -28.2M-27.67M-26.64M-28.01M-15.2M
Investing 8.99M157k-126k7.2M407k
Financing 18.28M5.4M39.52M3.24M9.36M
Market Cap 14.5M
Price to Earnings Ratio -1.72
Price to Sales Ratio 140
Price to Cash Ratio 2.07
Price to Book Ratio 2.3
Dividend Yield -

Share Statistics

Shares Outstanding 41.43M
Average Volume (1 week) 52.16k
Average Volume (1 Month) 22.03k
52 Week Change -44.27%
52 Week High 0.628
52 Week Low 0.212
Spread (Intraday) 0.04 (11.18%)

Company Info

Company Name Celyad Oncology SA
Address axis business park, , rue edouard belin 2
mont-saint-guibert, walloon brabant B-1435
Website https://www.celyad.com
Industry pharmaceutical preparations (2834)